To andre hovedundersøgelser sammenlignede Valdoxans og placebos evne til at forhindre, at symptomerne kom igen, hos 706 patienter, hvis depression allerede var kontrolleret med Valdoxan.
Two other main studies compared the ability of Valdoxan and placebo to prevent symptoms returning in 706 patients whose depression had already been controlled with Valdoxan.